- Home
- ANVS vs SHLT Comparison
ANVS vs SHLT Comparison
Compare ANVS & SHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- SHLT
- Stock Information
- Founded
- ANVS 2008
- SHLT 1987
- Country
- ANVS United States
- SHLT Israel
- Employees
- ANVS N/A
- SHLT N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- SHLT Business Services
- Sector
- ANVS Health Care
- SHLT Consumer Discretionary
- Exchange
- ANVS Nasdaq
- SHLT Nasdaq
- Market Cap
- ANVS 110.4M
- SHLT 63.6M
- IPO Year
- ANVS 2020
- SHLT N/A
- Fundamental
- Price
- ANVS $9.57
- SHLT $2.74
- Analyst Decision
- ANVS Strong Buy
- SHLT Strong Buy
- Analyst Count
- ANVS 6
- SHLT 1
- Target Price
- ANVS $29.67
- SHLT $11.00
- AVG Volume (30 Days)
- ANVS 341.4K
- SHLT 3.2K
- Earning Date
- ANVS 11-06-2024
- SHLT 09-26-2024
- Dividend Yield
- ANVS N/A
- SHLT N/A
- EPS Growth
- ANVS N/A
- SHLT N/A
- EPS
- ANVS N/A
- SHLT N/A
- Revenue
- ANVS N/A
- SHLT $55,939,000.00
- Revenue This Year
- ANVS N/A
- SHLT N/A
- Revenue Next Year
- ANVS N/A
- SHLT N/A
- P/E Ratio
- ANVS N/A
- SHLT N/A
- Revenue Growth
- ANVS N/A
- SHLT N/A
- 52 Week Low
- ANVS $4.53
- SHLT $2.60
- 52 Week High
- ANVS $22.49
- SHLT $10.44
- Technical
- Relative Strength Index (RSI)
- ANVS 58.70
- SHLT 37.68
- Support Level
- ANVS $9.00
- SHLT $2.64
- Resistance Level
- ANVS $10.54
- SHLT $2.89
- Average True Range (ATR)
- ANVS 0.81
- SHLT 0.12
- MACD
- ANVS 0.12
- SHLT 0.01
- Stochastic Oscillator
- ANVS 74.57
- SHLT 23.92
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.